RE: re-rate30 Jun 2018 10:08
Completely agree, this will be a medium term scenario. I fully expect the drug to be successful, that means that the current SP is a patch on its future valuation....but it is representative of the current information available.
I'm in profit as I came in at .22, in the long run I'm looking for £4-£6 but in the mean time I'm happy to hold and wait.
IMM, C4XD and FDBK have very bright futures imo but, at present, they're very much under the radar.